Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network.
{"title":"Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network.","authors":"Haijing Sun, Anna Wang, Shanshan He","doi":"10.3390/ijerph19084508","DOIUrl":null,"url":null,"abstract":"<p><p>Most current research on Alzheimer's disease (AD) is based on transverse measurements. Given the nature of neurodegeneration in AD progression, observing longitudinal changes in the structural features of brain networks over time may improve the accuracy of the predicted transformation and provide a good measure of the progression of AD. Currently, there is no cure for patients with existing AD dementia, but patients with mild cognitive impairment (MCI) in the prodromal stage of AD dementia may be diagnosed. The study of the early diagnosis of MCI and the prediction of MCI to AD transformation is of great significance for the monitoring of the MCI to AD transformation process. Despite the high rate of MCI conversion to AD, the neuropathological cause of MCI is heterogeneous. However, many people with MCI remain stable. Treatment options are different for patients with stable MCI and those with underlying dementia. Therefore, it is of great significance for clinical practice to predict whether patients with MCI will develop AD dementia. This paper proposes an improved algorithm that is based on a convolution neural network (CNN) with residuals combined with multi-layer long short-term memory (LSTM) to diagnose AD and predict MCI. Firstly, multi-time resting-state fMRI images were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database for preprocessing, and then an AAL brain partition template was used to construct a 90 × 90 functional connectivity (FC) network matrix of a whole-brain region of interest (ROI). Secondly, the diversity of training samples was increased by generating an adversarial network (GAN). Finally, a CNN with residuals and a multi-layer LSTM model were constructed to automatically classify and predict the functional adjacency matrix. This method can not only distinguish Alzheimer's disease from normal health conditions at multiple time points, but can also predict progressive MCI (pMCI) and stable MCI (sMCI) at multiple time points. The classification accuracies in AD vs. NC and sMCI vs.pMCI reached 93.5% and 75.5%, respectively.</p>","PeriodicalId":55542,"journal":{"name":"Aging Male","volume":"23 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2022-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030143/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging Male","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.3390/ijerph19084508","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Most current research on Alzheimer's disease (AD) is based on transverse measurements. Given the nature of neurodegeneration in AD progression, observing longitudinal changes in the structural features of brain networks over time may improve the accuracy of the predicted transformation and provide a good measure of the progression of AD. Currently, there is no cure for patients with existing AD dementia, but patients with mild cognitive impairment (MCI) in the prodromal stage of AD dementia may be diagnosed. The study of the early diagnosis of MCI and the prediction of MCI to AD transformation is of great significance for the monitoring of the MCI to AD transformation process. Despite the high rate of MCI conversion to AD, the neuropathological cause of MCI is heterogeneous. However, many people with MCI remain stable. Treatment options are different for patients with stable MCI and those with underlying dementia. Therefore, it is of great significance for clinical practice to predict whether patients with MCI will develop AD dementia. This paper proposes an improved algorithm that is based on a convolution neural network (CNN) with residuals combined with multi-layer long short-term memory (LSTM) to diagnose AD and predict MCI. Firstly, multi-time resting-state fMRI images were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database for preprocessing, and then an AAL brain partition template was used to construct a 90 × 90 functional connectivity (FC) network matrix of a whole-brain region of interest (ROI). Secondly, the diversity of training samples was increased by generating an adversarial network (GAN). Finally, a CNN with residuals and a multi-layer LSTM model were constructed to automatically classify and predict the functional adjacency matrix. This method can not only distinguish Alzheimer's disease from normal health conditions at multiple time points, but can also predict progressive MCI (pMCI) and stable MCI (sMCI) at multiple time points. The classification accuracies in AD vs. NC and sMCI vs.pMCI reached 93.5% and 75.5%, respectively.
期刊介绍:
The Aging Male , the official journal of the International Society for the Study of the Aging Male, is a multidisciplinary publication covering all aspects of male health throughout the aging process. The Journal is a well-recognized and respected resource for anyone interested in keeping up to date with developments in this field. It is published quarterly in one volume per year.
The Journal publishes original peer-reviewed research papers as well as review papers and other appropriate educational material that provide researchers with an integrated perspective on this new, emerging specialty. Areas of interest include, but are not limited to:
Diagnosis and treatment of late-onset hypogonadism
Metabolic syndrome and related conditions
Treatment of erectile dysfunction and related disorders
Prostate cancer and benign prostate hyperplasia.